22nd Century Group, Inc. (24)

Browse by Contract Category

Contracts

Securities Exchange Agreement between 22nd Century Group, Inc. and PLS, Exactus, Inc. dated June 30, 2021 (Filed With SEC on August 5, 2021)
First Amended and Restated Framework Collaborative Research Agreement between 22nd Century Group, Inc. and Keygene N.V. dated April 16, 2021 (Filed With SEC on August 5, 2021)
Form of Director RSU Award Agreement under 22nd Century Group, Inc. 2021 Omnibus Incentive Plan (Filed With SEC on May 21, 2021)
Promissory Note Exchange Agreement between 22nd Century Group, Inc. and Panacea dated June 30, 2021 (Filed With SEC on August 5, 2021)
Form of Securities Purchase Agreement, dated June 7, 2021, by and between 22nd Century Group, Inc. and each of the Purchasers (as defined therein) (Filed With SEC on June 7, 2021)
Placement Agent Agreement, dated June 7, 2021, between 22nd Century Group, Inc. and Cowen and Company, LLC (Filed With SEC on June 7, 2021)
Form of Executive RSU Award Agreement under 22nd Century Group, Inc. 2021 Omnibus Incentive Plan (Filed With SEC on May 21, 2021)
Form of Option Award Agreement under 22nd Century Group, Inc. 2021 Omnibus Incentive Plan (Filed With SEC on May 21, 2021)
Description of Securities Registered Pursuant to Section 12 (Filed With SEC on March 11, 2021)
Employment Agreement between the Company and James Mish (Filed With SEC on June 3, 2020)
Employment Agreement between the Company and John Franzino (Filed With SEC on June 3, 2020)
Description of Securities Registered Pursuant to Section 12 (Filed With SEC on March 11, 2020)
Employment Agreement between the Company and Andrea S. Jentsch (Filed With SEC on January 3, 2020)
Side Agreement, dated as of December 3, 2019, Panacea Life Sciences, Inc., [EMPLOYEE], [EMPLOYEE], [EMPLOYEE], [EMPLOYEE], Quintel-MC Incorporated, and 22nd Century Group, Inc (Filed With SEC on December 3, 2019)
Warrant to purchase shares of Series B Preferred Stock of Panacea Life Sciences., Inc., dated December 3, 2019, issued to 22nd Century Group, Inc (Filed With SEC on December 3, 2019)
Convertible Note of Panacea Life Sciences., Inc., dated December 3, 2019, issued to 22nd Century Group, Inc (Filed With SEC on December 3, 2019)
Series B Preferred Stock Purchase Agreement, dated as of December 3, 2019, between Panacea Life Sciences., Inc and 22nd Century Group, Inc (Filed With SEC on December 3, 2019)
Form of Warrant Exercise Agreement (Filed With SEC on November 25, 2019)
Form of New Warrant Agreement (Filed With SEC on November 25, 2019)
Employment Agreement between the Company and Michael J. Zercher (Filed With SEC on September 13, 2019)
Employment Agreement between the Company and Clifford B. Fleet (Filed With SEC on September 13, 2019)
Framework Collaborative Research Agreement, dated as of April 3, 2019, between KeyGene N.V. and 22nd Century Group, Inc (Filed With SEC on May 7, 2019)
Form of Director Restricted Stock Unit Award Agreement under 22nd Century Group, Inc. 2014 Omnibus Incentive Plan, as amended and restated (Filed With SEC on March 6, 2019)
Form of Executive Restricted Stock Unit Award Agreement under 22nd Century Group, Inc. 2014 Omnibus Incentive Plan, as amended and restated (Filed With SEC on March 6, 2019)